About COUP transcription factor 2
COUP transcription factor 2 (NR2F2) is a protein
from Homo sapiens identified by UniProt accession
P24468, 414 residues long.
MolForge cross-references it against 0 known binders and
360 disease associations.
Target properties
| Protein name | COUP transcription factor 2 |
| UniProt accession | P24468 |
| Gene | NR2F2 |
| Organism | Homo sapiens |
| Length | 414 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (360)
Diseases linked to this target (Open Targets).
- congenital heart disease · score 0.73
- 46,xx sex reversal 5 · score 0.58
- neurodegenerative disease · score 0.54
- genetic disorder · score 0.50
- sex hormone-binding globulin measurement · score 0.42
- Parkinson disease · score 0.31
- cortical surface area measurement · score 0.31
- Alzheimer disease · score 0.30
- lysosomal storage disease · score 0.30
- multiple sclerosis · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P24468-F1 | alphafold | PREDICTED | 76.75 | — |
Amino-acid sequence (414 residues)
MAMVVSTWRD PQDEVPGSQG SQASQAPPVP GPPPGAPHTP QTPGQGGPAS TPAQTAAGGQ GGPGGPGSDK QQQQQHIECV VCGDKSSGKH YGQFTCEGCK SFFKRSVRRN LSYTCRANRN CPIDQHHRNQ CQYCRLKKCL KVGMRREAVQ RGRMPPTQPT HGQFALTNGD PLNCHSYLSG YISLLLRAEP YPTSRFGSQC MQPNNIMGIE NICELAARML FSAVEWARNI PFFPDLQITD QVALLRLTWS ELFVLNAAQC SMPLHVAPLL AAAGLHASPM SADRVVAFMD HIRIFQEQVE KLKALHVDSA EYSCLKAIVL FTSDACGLSD VAHVESLQEK SQCALEEYVR SQYPNQPTRF GKLLLRLPSL RTVSSSVIEQ LFFVRLVGKT PIETLIRDML LSGSSFNWPY MAIQ
Explore COUP transcription factor 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets